AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 201 filers reported holding AMICUS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $451,000 | -21.6% | 37,325 | +1.2% | 0.29% | -15.5% |
| Q2 2018 | $575,000 | +18.1% | 36,870 | +14.0% | 0.35% | +19.2% |
| Q1 2018 | $487,000 | -1.6% | 32,356 | -6.0% | 0.29% | +1.0% |
| Q4 2017 | $495,000 | -4.6% | 34,406 | 0.0% | 0.29% | -1.0% |
| Q3 2017 | $519,000 | +39.5% | 34,406 | -6.8% | 0.29% | +43.1% |
| Q2 2017 | $372,000 | +9.7% | 36,905 | -22.3% | 0.20% | +4.6% |
| Q1 2017 | $339,000 | +67.8% | 47,525 | +16.8% | 0.20% | +56.0% |
| Q4 2016 | $202,000 | -36.5% | 40,700 | -5.3% | 0.12% | -38.4% |
| Q3 2016 | $318,000 | +421.3% | 42,995 | +283.9% | 0.20% | +407.5% |
| Q2 2016 | $61,000 | +52.5% | 11,200 | -10.4% | 0.04% | +48.1% |
| Q1 2013 | $40,000 | – | 12,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |